TABLE 3.

Summary of statistically significant kinases identified that either increase (+) or decrease (−) total or phospho-tau levels

41 kinases from the first round (shown in Table 1) together with NIM1, SIK2, MAPK11, TTBK1, and TTBK2 were rescreened. The kinases validated in the second round of screening are shown.